# CYSTIC FIBROSIS

## 定義 and 病生理 (_NEJM_ 2015;372:351)

• Autosomal recessive genetic disorder due to mutations in chloride channel (CFTR gene)

• ↑ mucus thickness, ↓ mucociliary clearance, ↑ infections → bronchiectasis

## 臨床表現

• Recurrent PNA, sinus infections

• Distal intestinal obstruction syndrome (DIOS), pancreatic insufficiency (steatorrhea, malabsorption, failure to thrive, weight loss), CF-related diabetes, infertility

## 治療 (_Lancet_ 2016;388:2519)

• Acute exacerbations: may be assoc with persistent drop in FEV1 (_AJRCCM_ 2010;182:627); continue aggressive airway clearance, target 抗生素 based on sputum cx (incl double coverage for PsA); common pathogens include PsA, _S. aureus_, non-typeable _H flu_, _Stenotrophomonas_, _Burkholderia_, NTM

• Chronic mgmt: airway clearance with chest PT, inhaled hypertonic saline, inhaled DNAse (dornase alfa), SABA; oral azithromycin if chronic respiratory symptoms, inhaled tobramycin or aztreonam if persistent PsA infection

• CFTR potentiator (ivacaftor) or corrector (lumacaftor, tezacaftor) depending on mutation; combination approved for patients homozygous for ΔF508 (most common mutation) (_NEJM_ 2011;365:1663; 2015;373:220; 2017;377:2013 & 2024)

• Lung transplantation; refer to lung transplant center when FEV1 <30% predicted, rapidly declining FEV1, 6MWT <400 m, evidence of PHT, significant 臨床decline
